Basic information
Biomarker: HE4
Histology type: endometrial carcinoma
Stage: high risk
Cohort characteristics
Country: Italy
Region: Brescia
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
186 | EC | 153 | NE | 33 |
Sample information
Conclusion: Protein and HE4 gene were significantly upregulated in EC tissues and sera, compared with controls. High sHE4 levels were significantly associated with worse EC clinical characteristics
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : expression
Expression elevation: Cytoplasmic staining was graded for intensity (0-negative, 1-weak, 2-moderate and 3-strong) and the percentage of positive cells was scored as 0 (0%), 1 (1–10%), 2 (11–50%) and 3 (51–100%). A single scale with scores 0–9 was obtained by multiplying the intensity and the percentage staining score, and a total score was calculated by grouping score 0 in total score 0, 1–3 in total score 1, 4 and 6 in total score 2 and 9 in total score 3.
Disease information
Statictics: cutoff<65;cutoff>65
Cohort age: 60;78
Related information
Funtion Uniprot: Broad range protease inhibitor.
UniProt ID: Q14508
UniProt Link: https://www.uniprot.org/uniprotkb/Q14508/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in a number of normal tissues, including male reproductive system, regions of the respiratory tract and nasopharynx. Highly expressed in a number of tumors cells lines, such ovarian, colon, breast, lung and renal cells lines. Initially described as being exclusively transcribed in the epididymis.
Subcellular UniProt: #Secreted
Alternative name from UniProt:
Recommended name: WAP four-disulfide core domain protein 2
Gene name from HGNC: WFDC2 (dJ461P17.6, EDDM4, HE4, WAP5)
HPA class: Cancer-related genes
AlphaFold DB: Q14508
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/Q14508
HPA link: https://www.proteinatlas.org/ENSG00000101443-WFDC2
Tissue specificity RNA from HPA: Tissue enhanced (cervix, salivary gland)
Tissue expression from HPA: Cytoplasmic expression in selected tissues.
Single cell type specificity Cell type enhanced (Club cells, Glandular and luminal cells, Basal respiratory cells, Urothelial cells, Endometrial ciliated cells, Respiratory ciliated cells, Collecting duct cells)
Immune cell specificity: Not detected in immune cells
Subcellular summary HPA Secreted
Cancer prognostic summary HPA Prognostic marker in glioma (unfavorable) and renal cancer (favorable)
Pathology link: https://www.proteinatlas.org/ENSG00000101443-WFDC2/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000101443-WFDC2//pathology/endometrial+cancer
Expression figure legend: Representative immunohistochemical staining for HE4
Expression figure link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101927/figure/fig2/
Survival figure legend: Kaplan–Meier survival curves for EC patients according to sHE4 levels on the entire patient cohort
Survival curve link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101927/figure/fig4/
OMIM: 617548
OMIM link2: https://www.omim.org/entry/617548
HGNC ID: HGNC:15939
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:15939